A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Absci Corp stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 142,018 shares of ABSI stock, worth $478,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares
142,018
Previous 94,550 50.2%
Holding current value
$478,600
Previous $291,000 86.25%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$2.97 - $4.49 $140,979 - $213,131
47,468 Added 50.2%
142,018 $542,000
Q2 2024

Jul 19, 2024

BUY
$2.92 - $6.58 $125,107 - $281,920
42,845 Added 82.86%
94,550 $291,000
Q1 2024

Apr 22, 2024

BUY
$3.41 - $5.74 $66,955 - $112,704
19,635 Added 61.23%
51,705 $293,000
Q4 2023

Jan 16, 2024

BUY
$1.15 - $4.79 $36,880 - $153,615
32,070 New
32,070 $134,000

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $313M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.